No detailed analysis has been performed to date, possibly due to the fact that mutations in the Nf2 gene have thus far been related to the development of schwannomas, meningiomas and gliomas—but have not been described in patients harboring oligodendrogliomas [2,30,31]. The gene discussed is NF2; the disease is meningioma.